Related Experiment Video
Updated: Jan 23, 2026

Visualization of Biofilm Formation in Candida albicans Using an Automated Microfluidic Device
Published on: December 14, 2017
Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans
Angélica de L Rodríguez López1, Myung-Ryul Lee2, Nathan B Wang2
1Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Abstract:
Candida albicans is an opportunistic fungal pathogen responsible for mucosal candidiasis and systemic candidemia in humans. Often, these infections are associated with the formation of drug-resistant biofilms on the surfaces of tissues or medical devices. Increased incidence of C. albicans resistance to current antifungals has heightened the need for new strategies to prevent or eliminate biofilm-related fungal infections. In prior studies, we designed 14-helical β-peptides to mimic the structural properties of natural antimicrobial α-peptides (AMPs) in an effort to develop active and selective antifungal compounds. These amphiphilic, cationic, helical β-peptides exhibited antifungal activity against planktonic C. albicans cells and inhibited biofilm formation in vitro and in vivo Recent studies have suggested the use of antivirulence agents in combination with antifungals. In this study, we investigated the use of compounds that target C. albicans polymorphism, such as 1-dodecanol, isoamyl alcohol, and farnesol, to attempt to improve β-peptide efficacy for preventing C. albicans biofilms. Isoamyl alcohol, which prevents hyphal formation, reduced the minimum biofilm prevention concentrations (MBPCs) of β-peptides by up to 128-fold. Combinations of isoamyl alcohol and antifungal β-peptides resulted in less than 10% hemolysis at the antifungal MBPCs. Overall, our results suggest potential benefits of combination therapies comprised of morphogenesis modulators and antifungal AMP peptidomimetics for preventing C. albicans biofilm formation.
Insights
New antifungal β-peptides show promise in preventing drug-resistant Candida albicans biofilms. Combining these peptides with isoamyl alcohol significantly enhances efficacy and reduces treatment toxicity.
Area of Science:
- Mycology
- Biochemistry
- Antimicrobial drug development
Background:
- Candida albicans causes serious infections, often forming drug-resistant biofilms.
- Rising antifungal resistance necessitates novel strategies for biofilm control.
- Antimicrobial peptides (AMPs) are a potential source for new antifungal agents.
Purpose of the Study:
- To investigate the efficacy of novel 14-helical β-peptides against Candida albicans biofilms.
- To evaluate the synergistic potential of combining β-peptides with morphogenesis modulators like isoamyl alcohol.
- To assess the safety profile of these combination therapies.
Main Methods:
- Design and synthesis of 14-helical β-peptides mimicking natural AMPs.
- In vitro and in vivo testing of β-peptides for antifungal and antibiofilm activity.
- Combination studies with morphogenesis modulators (1-dodecanol, isoamyl alcohol, farnesol) to determine Minimum Biofilm Prevention Concentrations (MBPCs).
- Hemolysis assays to evaluate compound toxicity.
Main Results:
- Amphiphilic, cationic β-peptides demonstrated antifungal activity and inhibited biofilm formation.
- Isoamyl alcohol significantly reduced the MBPCs of β-peptides by up to 128-fold.
- Combination therapies showed minimal hemolysis (<10%) at effective concentrations.
Conclusions:
- Combination therapy of morphogenesis modulators and antifungal β-peptides offers a promising strategy for preventing Candida albicans biofilms.
- This approach may overcome current antifungal resistance challenges.
- Further development of these combination therapies could lead to improved treatments for candidiasis.
Related Concept Videos
Peptide Bonds
Morphogenesis
Molecules and Compounds
Cancer Prevention
Some...
Biofilms
Self-Evaluation: Self-Enhancement and Self-Verification

